Glucose for the heart

Circulation

Volumn 99, Issue 4, 1999, Pages 578-588

  Depre, Christophe ^a,b,f   Vanoverschelde, Jean Louis J ^c,d   Taegtmeyer, Heinrich ^e  

^a Department of Internal Medicine ^*  (Belgium)

^b University of Texas Houston Medical School   (Belgium)

^c Institute of Cellular Pathology   (Belgium)

^d UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Glucose; Heart failure; Ischemia; Metabolism; Myocardium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; CREATINE PHOSPHATE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE 6 PHOSPHATE; INSULIN; POTASSIUM;

CITRIC ACID CYCLE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN METABOLISM; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER;

EID: 0033514322     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.4.578     Document Type: Review

References (152)

1. Opie LH. Metabolism of the heart in health and disease. Am Heart J. 1968;76:685-693.
2. Lopaschuk GD, Saddik M. The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol CellBiochem. 1992;! 16:111-116.
3. Depre C, Vanoverschelde JL, Melin JA, Borgers M, Bol A, Ausma J, Dion R, Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischémie dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.
4. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 1988;! 1: 416-426.
5. Rändle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963:1:785-789.
6. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta. 1994;1213:263-276.
7. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 1994;19:57-116.
8. Russell RR, Cline GW, Guthrie PH, Goodwin GW, Shulman Gljaegtmeyer H. Régulation of exogenous and endogenous glucose metabolism by insulin and acetoacetate in the isolated working rat heart J Clin Invest. 1997:100: 2892-2899.
9. Sokoloff L, Reivich M, Kennedy C, Des Rosiers M, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [MC] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem. 1977;28:897-916.
10. Patlak C, Blasberg R, Fenstermacher J. Graphical evaluation of bloodto-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:l-7.
11. Schwaiger M, Scheiben H, Ellison D, Hansen H, Yeatman L, VintenJohanssen J, Selin C, Barrio J, Phelps M. Sustained regional abnor-malities in cardiac metabolism after transient ischemia in the chronic dog model. 7 A Coll Cariiiol. 1985;6:337-347.
12. Nguyen V, Mossberg K, Tew son T, Wong W, Rowe R, Coleman G, Taegtmeyer H. Temporal analysis of myocardial glucose metabolism by 18F-2-deoxy-2-fluoro-D-glucose. Am J Physiol. 1990;259:H1011H1031.
13. Ratib O, Phelps M, Huang S, Henze E, Selin C, Scheiben H. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nttcl Med. 1982:23:577-586.
14. Taegtmeyer H. Utility and limitations of 18F-2-deoxy-2-fIuoro-D-glucose for the assessment of flux through metabolic pathways in heart muscle: a critical appraisal. In: Schwaiger M. ed. Cardiac Positron Emission Tomography. Norwell, Mass: Kluwer Academic Publishers; 1996: 79-96.
15. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H. Fundamental limitations of ['8F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995;91:2435-2444.
16. Botker HE, Doenst T, Holden JE, Taegtmeyer H. Mechanisms of myocardial glucose uptake assessed by simultaneous determinations of glucose and fluorodeoxyglucose kinetic behavior. Circulation. 1997; 96(suppl I):I-690. Abstract.
17. Pessin JE, Bell GI. Mammalian facultative glucose transporter family: structure and molecular regulation. Anna Rev Physiol. 1992;54:911 -930.
18. Could GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J. 1993;295:329-341.
19. Muecklcr M. Facilitative glucose transporters. Ear J Biochem. 1994; 219:713-725.
20. Nishimura H, Pallardo FV, Seidncr GA, Vannucci S, Simpson IA, Birnbaum MF. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem. 1993;268:8514-8520.
21. Shepherd PR, Gould GW, Colville CA, McCoid SC, Gibbs EM, Kahn BB. Distribution of GLUT 3 glucose transporter in human tissues. Biochem Biophys Res Commun. 1992;I88:149-154.
22. Printz RL, Koch S, Potter LR, O'Dohcrty RM, Tiesinga JJ, Moritz S, Granner DK. Hexokinase II mRNA and gene structure,- regulation by insulin, and evolution. J Biol Chem. 1993:268:5209-5219.
23. Arora KK, Pedersen DL. Functional significance of mitochondria! bound hexokinase in tumor cell metabolism: evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem. 1988:263:17422-17428.
24. Russell RR, Mrus JM, Mommesin JI, Taegtmeyer H. Compartmentation of hexokinase in rat heart: a critical factor for tracer kinetic analysis of myocardial glucose metabolism. J Clin lin-est. I992;90:1972-1977.
25. Newsholme EA, Crabtree B. Theoretical principles in the approaches to control of metabolic pathways and their application to glycolysis in muscle. J Mol Cell Cardiol. 1979;! 1:839-856.
26. Shelley HJ. Cardiac glycogen in different species before and after birth. Br Med Bull. 196I;17:137-156.
27. Schneider CA. Nguyen VTB, Taegtmeyer H. Feeding and fasting determine postischemic glucose utilization in isolated working rat hearts. Am J Physiol. 1991 ;260:H542-H548.
28. Moule SK, Denton RM. Multiple pathways involved in the metabolic effects of insulin. Am J Cardiol. 1997;80:41A-49A.
29. Depre C, Veitch K, Hue L. Role of fructose 2,6-bisphosphate in the control of glycolysis: stimulation of glycogen synthesis by lactate in the isolated working rat heart. Ada Cardiol. 1993;48:147-164.
30. Laughlin MR, Taylor J, Chesnick AS, Balaban RS. Nonglucose substrates increase glycogen synthesis in vivo in dog heart. Am J Physiol. I994;267:H219-H223.
31. Goodwin GW, Arteaga JR, Taegtmeyer H. Glycogen turnover in the isolated working rat heart. J Biol Chem. 1995:270:9234-9240.
32. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest. 1985;76:1819-1827.
33. Morgan HE, Parmeggiani A. Regulation of glycogenolysis in muscle, II: control of glycogen phosphorylase reaction in isolated perfused heart. J Biol Chem. 1964:239:2435-2439.
34. Goodwin G, Ahmad F, Taegtmeyer H. Preferential oxidation of glycogen in isolated working rat heart. J Clin Invest. 1996;97: 1409-1416.
35. Henning SL, Wambolt RB, Schönekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation. 1996;93:1549-1555.
36. Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol. 1994;267:H1862-H1871.
37. Goodwin GW, Ahmad F, Doenst T, Taegtmeycr H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol. 1998;274:H1239-H1247.
38. Uyeda K. Phosphofructokinase. Adv En-ymol Relat Areas Mol Biol. 1979;48:193-244.
39. Garland PB, Rändle PJ, Newsholme EA. Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation. Nature. 1963;200: 169-170.
40. Passonneau JV, Lowry OH. Phosphofructokinase and the Pasteur effect. Biochem Biophys Res Commun. 1962:7:10-15.
41. Hue L, Rider MH. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem J. 1987:245:313-324.
42. Depre C, Rider MH, Veitch K, Hue L. Role of fructose 2,6-bisphosphate in the control of heart glycolysis. J Biol Chcm. 1993:268:13274-13279.
43. Hue L, Maisin L, Rider MH. Palmitate inhibits glycolysis: involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. Biochem J. 1988:251:541-545.
44. Depre C, Ponchaut S, Deprez J, Maisin L, Hue L. Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. J Clin Invest. 1998:101:390-398.
45. Mochizuki S, Neely JR. Control of gIyceraldehyde-3-phosphate dehydrogenase in cardiac muscle. J Mol Cell Cardiol. 1979;! 1:221-236.
46. Kiffmeyer WR, Farrar W\V. Purification and properties of pig heart pyruvate kinase. J Protein Chem. 1991:10:585-591.
47. Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol. 1993; 264:C761-C782.
48. Peukhurinen KJ, Nuutinen EM, Pietilainen EP, Hiltunen JK, Hassinen IE. Role of pyruvate carboxylation in the energy-linked regulation of pool sizes of TCA-cycIe intermediates in the myocardium. Biochem J. 1982:208:577-581.
49. Russell RR, Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest. 1991;87:384-390.
50. Russell RR, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing oxaloacetate. Am J Physiol. 1991;30:H756-H762.
51. Reinauer H, Muller-Rucholtz ER. Regulation of the pyruvate dehydrogenase activity in the isolated perfused heart of guinea-pigs. Biochim Biophys Acta. 1976:444:33-42.
52. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev. 1990;70:391-425.
53. McGarry JD, Mills SE, Long CS, Foster DW. Observations of the affinity for carnitine, and malonyl-CoA sensitivity, of camitine palmitoyltransferase I in animal and human tissues. Biochem J. 1983:214: 21-28.
54. Awan MM, Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J. 1993:295:61-66.
55. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acelyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem. 1993:268:25836-25845.
56. Russell RR, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol. 1991;261:H1756-H1762.
57. Safer B, Williamson JR. Mitochondrial-cytosolic interactions in perfused rat heart. J Biol Chem. 1973:248:2570-2579.
58. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, Bergman J, Solin O, Voipio-Pulkki LM, Wegelius U, Yki-Järvinen H. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992:89:1767-1774.
59. Rändle PJ, Newsholme EA, Garland PB. Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochemistry. 1964;93: 652-687.
60. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy providing substrates in the isolated working rat heart. Biochem J. 1980:186: 701-711.
61. Gertz EW, Wisneski JA, Neese RA, Bristow JD, Searle CL, Hanlon JT. Myocardial lactale metabolism: evidence of lactate release during net chemical extraction in man. Circulation. 1981;63:1273-1279.
62. Chatham JC, Forder JR. Metabolic compartmentation of lactate in the glucose-perfused rat heart. Am J Physiol. 1996;270:H224-H229.
63. Gertz EW, Wisheski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans. J Clin Invest. 1988;82:2017-2025.
64. Taegtmeyer H. On the inability of ketone bodies to serve as the only energy providing substrate for rat heart at physiological work load. Basic Res Cardiol. 1983:78:435-450.
65. Dobson JGJ, Ross JJ, Mayer SE. The role of cyclic adenosine 3',5'monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle. Circ Res. 1976;39:388-395.
66. Watanabe T, Smith MM, Robinson FW, Kono T. Insulin action on glucose transport in cardiac muscle. J Biol Chem. I984;259: 13117-13122.
67. Wheeler TJ, Fell RD, Hauck MA. Translocation of two glucose transporters in heart: effects of rotenone, uncouplers, workload, palmitate, insulin and anoxia. Biochim Biophys Acta. 1994;! 196:191-200.
68. Lawson JWR, Uyeda K. Effect of insulin and work on fructose 2,6bisphosphate content and phosphofructokinase activity in perfused rat heans. J Biol Client. 1987;262:3165-3173.
69. Seymour AM, Eldar H, Radda GK. Hyperthyroidism results in increased glycolytic capacity in the rat heart: a 3IP NMR study. Biochim Biophys Acta. 1990;1055:107-116.
70. Gualberto A, Molinero P, Sobrino F. The effect of experimental hypothyroidism on phosphofructokinase activity and fructose 2,6bisphosphate concentrations in rat heart. Biochem J. 1987;244:137-142.
71. Castello A, Rodriguez-Manzaneque JC, Camps M, Perez-Castillo A, Testar X, Palacin M, Santos A, Zorzano A. Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. J Biol Chem. 1994;269:5905-5912.
72. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967;212:804-814.
73. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation. 1985;72:l-8.
74. Zaninetti D, Greco-Perotto R, Jeanrenaud B. Heart glucose transport and transporters in rat heart: regulation by insulin, workload and glucose. Diabetologia. 1988;31:I08-113.
75. Bing RJ. The metabolism of the heart. Han-ey Lect. 1955;50:27-70.
76. Morgan HE, Henderson MJ, Regen DM, Park CR. Regulation of glucose uptake in muscle, I: the effects of insulin and anoxia on glucose transport and phosphorylation in the isolated perfused heart of normal rats. J Biol Chem. 1961:236:253-261.
77. Bolukoglu H, Goodwin GW, Guthrie PH. Carmical SG, Chen MT, Taegtmeyer H. Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol. I996;270:H817-H826.
78. Stanley WC, Hall JL, Stone CK, Hacker TA. Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. Am J Physiol. 1992;262:H91-H96.
79. Neely JR, Grotyohann L\V. Role of glycolytic products in damage to myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused canine myocardium. Circ Res. 1984;55: 816-824.
80. Bricknell OL, Danes PS, Opie LH. A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol. I981;13:941-945.
81. McElroy DD, Walker WE, Taegtmeyer H. Glycogen loading improves left ventricular function of the rabbit heart after hypothermie ischémie arrest. J Appl Cardiol. 1989;4:455-465.
82. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischémie injury and functional recovery after reperfusion. Am J Physiol. 1994;267: H1785-H1794.
83. Depre C, Vanoverschelde J-L, Goudemant J-F, Mottet I, Hue L. Protection against ischémie injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 1995; 92:1911-1918.
84. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischémie myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultraslructure during ischemia and reperfusion. Cire Res. 1983;52: 515-526.
85. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apslein CS. Proteclive effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 1991;68:466-48I.
86. King LM, Boucher F, Opie LH. Coronary flow and glucose delivery as determinants of contracture in the ischémie myocardium. J Mol Cell Cardiol. 1995:27:701-720.
87. Chen TM, Goodwin GW, Guthrie PH, Taegtmeyer H. Effects of insulin on glucose uptake by rat hearts during and after coronary flow reduction. Am J Physiol. 1997;273:H2170-H2177.
88. Chin ER, Allen DG. Effects of reduced muscle glycogen concentration on force, Ca++ release and contractile protein function in intact mouse skeletal muscle. J Physiol (Land). 1997:498:17-29.
89. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res. 1996:79:940-948.
90. Lopaschuk GD, Stanley WC. Glucose metabolism in the ischémie heart. Circulation. 1997;95:313-315.
91. Wheeler TJ. Translocation of glucose transporters in response to anoxia in heart. J Biol Chem. 1988:263:19447-19454.
92. Sun D, Nguyen N, Delgrado T, Schwaiger M, Brosius FC. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT 4 to the plasma membrane of cardiac myocytes. Circulation. 1994:89:793-798.
93. Dona-Medina CL, Lund DD, Pasley A, Sandra A, Sivitz WI. Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue. Am J Physiol. 1993;265:E454E464.
94. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI, Sinusas AJ. Low-flow ischemia leads to a translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415-422.
95. Shelly M, Loeb JN, Ismail-Beigi F. Enhancement of glucose transport in response to inhibition of oxidative metabolism: pre- and posttranslational mechanisms. Am J Physiol. 1992;262:C527-C532.
96. Bashan N, Burdett E, Guma A, Sargeant R, Tumiati L, Liu Z, Klip A. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol. 1993;264:C430C440.
97. Shetty M, Ismail-Beigi N, Loeb JN, Ismail-Beigi F. Induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation. Am J Physiol. 1993;265:C1224-C1229.
98. Vanoverschelde J-LJ, Janier MF, Bergmann SR. The relative importance of myocardial energy metabolism compared with ischémie contracture in the determination of ischémie injury in perfused rabbit hearts. Circ Res. 1994:74:817-828.
99. Depre C, Hue L. Cyclic GMP in perfused rat heart: effect of ischaemia, anoxia and nitric oxide synthase inhibitor. FEES Lett. 1994;345: 241-245.
100. Depre C, Fierain L, Hue L. Activation of nitric oxide synthase by ischemia in the perfused heart. Cardiovasc Res. 1997;33:82-87.
101. Depre C, Gaussin V, Ponchaut S, Fischer Y, Vanoverschelde JLJ, Hue L. Inhibition of myocardial glucose uptake by cyclic GMP. Am J Physiol. 1998;274:H1443-HI449.
102. Newsholme EA. The regulation of phosphofructokinase in muscle. Cardiology. 1971:56:22-34.
103. Goudemant JF, Brodure G, Mottet I, Demeure R, Melin J, Vanoverschelde JL. Inhibition of Na/K-ATPase abolishes the protection afforded by glycolysis against myocardial ischémie injury. Circulation. 1995;92(suppl I):I-631. Abstract
104. McDonald T, Mac Leod D. Metabolism and the electrical activity of ventricular muscle. J Physiol (Land). 1973:229:559-582.
105. Scheuer J, Stezoski SW. Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat. Circ Res. 1970:27:835-849.
106. Lagerstrom CF, Walker WE, Taegtmeyer H. Failure of glycogen depletion to improve left ventricular function of the rabbit heart after hypothermie ischémie arrest. Circ Res. 1988:63:81-86.
107. Schneider CA, Taegtmeyer H. Fasting in vivo delays myocardial cell damage after brief periods of ischemia in the isolated working rat heart. Circ Res. 1991:68:1045-1050.
108. Docnst T, Guthrie PH, Chemnitius JM, Zech R, Taegtmeyer H. Fasting, laclate, and insulin improve ischemia tolerance: a comparison with ischémie preconditioning. Am J Physiol. 1996;270:H1607-H1615.
109. Dcpre C, Hue L. Inhibition of glycogenolysis by a glucose analogue in the working rat heart. J Mol Cell Cardiol. 1997:29:2253-2259.
110. Runnman EM, Lamp ST, Weiss JN. Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux. / Clin Invest. 1990;86:1222-1233.
111. Cross HR, Opie LH, Radda GK, Clarke K. Is a high glycogen content beneficial or detrimental to the ischémie rat heart?: a controversy resolved. Circ Res. 1996;78:482-491.
112. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng \V, Melin J. Chronic myocardial hibernation: from bedside to bench. Circulation. 1997;95:I961-1971.
113. Borgers M, Thoné F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis. Cardiovasc Palhol. 1993;2:237-245.
114. Elsasser A, Schleper M, Klovekorn WP, Cai WP, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, Schapcr J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
115. Maki M, Luotolahti M, Nuutila P, lida H, Voipio-Pulkki LM, Ruotsalainen U, Haaparenta M, Solin O, Hartiala J, Harkonen R, Knuuti MI. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 1996;93:1658-1666.
116. Depre C, Vanoverschelde JL, Gerber B, Borgers M, Melin J, Dion R. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischémie dysfunction undergoing coronary artery bypass grafting. J Tliorac Cardiovasc Surg. 1997;! 13:371-378.
117. Thompson EW, Marino TA, Uboh CE, Kent RL, Cooper G. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res. 1984;54:367-377.
118. Depre C, Havaux X, Dion R, Vanoverschelde JL. Morphologic alterations of myocardium under left ventricular assistance. J Tliorac Cardiovasc Surg. 1998;! 15:478-479.
119. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:HI306-H1315.
120. Weiss RG, de Albuquerque CP, Vandegaer K, Chacko VP, Gerstenblith G. Attenuated glycogenolysis reduces glycolytic catabolite accumulation during ischemia in preconditioned rat hearts. Circ Res. 1996;79:435-446.
121. Wolfe CL, Sievers RE, Visseren FLJ, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time-course of glycogen recovery within the preconditioned segment. Circulation. 1990;66:913-931.
122. Kida M, Fujiwara H, Ishida M, Keuwon C, Ohura M, Miura I, Yabunclin Y. Ischémie preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991:84:2495-2503.
123. Liedtke AJ, Demaison L, Nellis SH. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 1988; 255:169-176.
124. Gorge G, Châtelain P, Schaper J, Lerch R. Effect of increasing degrees of ischémie injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res. 1991;68:1681-1692.
125. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Circ Res. 1992;71: 567-576.
126. Liu B, Alaoui-Talibi Z, Clanachan AS, Schultz R, Lopaschuk GD. Uncoupling of contractile function from mitochondria! TCA cycle activity and MVO^ during reperfusion of ischémie hearts. Am J Physiol. 1996;270:H72-H80.
127. Mallet RT, Hartman DA, Biinger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem. 1990;188:481-493.
128. Jeremy RW, Koretsune Y, Marban E, Becker LC. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res. 1992;70:1180-1190.
129. Tamm C, Benzi RH, Papageorgiou I, Tardy I, Lerch R. Substrate competition in postischemic myocardium: effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. Circ Res. 1994:75:1103-1112.
130. du Toit EF, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res. 1992:70:960-967.
131. McVeigh JJ, Lopaschuk GD. Dichloroacelate stimulation of glucose oxidation improves recovery of ischémie rat hearts. Am J Physiol. 1990;259:H1079-H1085.
132. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991;68: 1250-1258.
133. Tani M. Mechanism of Caoverload in reperfused ischémie myocardium. Anna Rev Physiol. 1990;52:543-559.
134. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischémie hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995:270:17513-17520.
135. Kudo N, Gillespie JG, Kung L, Witters, LA, Schulz R, Clanachan AS, Lopaschuk GD. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Ada. 1996; 1301:67-75.
136. Bunger R, Mallet RT, Hartman DA. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Ear J Biochem. 1989:180:221-233.
137. De Leiris J, Lubbe WF, Opie LH. Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction. Nature. 1975; 153:746-747.
138. Sodi-Pallares D, Testelli MR, Fishleder BL. Effects of intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol. 1962:9:166-181.
139. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation. 1972:45:1160-1175.
140. Rogers WJ, Stanley AW, Breing JB, Prattler JW, McDaniel HG, Moraski RE, Mantle JA, Russell RO, Rackley CE. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulinpotassium infusion. Am Heart J. 1976:92:441-454.
141. Whitlow PL, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Mantle JA, Logic JR, Russell RO, Rackley CE. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1982;49:811-820.
142. Sailer LF, Green CE, Kent KM, Pallas RS, Pearle DL, Rackley CE. Metabolic support during coronary repcrfusion. Am Heart J. 1987;! 14: 54-58.
143. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995:26:57-65.
144. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
145. Schaefer S, Prussel E, Carr LJ. Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia. J Mol Cell Cardiol. 1995:27:2167-2176.
146. Taegtmeyer H, Villalobos DH. Metabolic support for the postischaemic heart. Lancet. 1995:345:1552-1555.
147. Lazar HL. Enhanced preservation of acutely ischémie myocardium using glucose-insulin-potassium solutions. J Card Surg. 1984;9:474-478.
148. Gradinak S, Coleman CM, Taegtmeyer H, Sweeney F, Frazier H. Improved cardiac function with glucose-insulin-potassium after coronary bypass surgery. Ann Thorac Surg. 1989:48:484-489.
149. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol. 1997;80:3A-10A.
150. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Sherwin RI, Apstein CS. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997:113:354-362.
151. O'Rourke B, Ramza BM, Marban E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science. 1994:265:962-966.
152. Lolley DM, Ray JF, Myers WO, Sauter RD, Tewksbury DA. Importance of preoperative myocardial glycogen levels in human cardiac preservation. Cardiovasc Surg. 1979;78:678-687.